We serve Chemical Name:2-(Bromomethyl)-1-iodo-4-(trifluoromethyl)benzene CAS:702641-06-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(Bromomethyl)-1-iodo-4-(trifluoromethyl)benzene
CAS.NO:702641-06-3
Synonyms:Benzene, 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)-;2-(Bromomethyl)-1-iodo-4-(trifluoromethyl)benzene
Molecular Formula:C8H5BrF3I
Molecular Weight:364.929
HS Code:2903999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:268.3±40.0 °C at 760 mmHg
Density:2.1±0.1 g/cm3
Index of Refraction:1.564
PSA:
Exact Mass:363.857117
LogP:4.92
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzene, 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Bromomethyl)-1-iodo-4-(trifluoromethyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene, 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)- Use and application,Benzene, 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)- technical grade,usp/ep/jp grade.
Related News: Brian McNamara, currently head of GSK’s consumer healthcare division, will continue to serve as the franchise’s CEO after it breaks away from GSK in 2022, the British pharma said Thursday. 2-methyl-2-(4-methyl-2-oxo-3-(piperidin-1-ylmethyl)pent-3-en-1-yl)-2,3-dihydroindolizine-1,5-dione manufacturers TULIP-2 assessed the effect of anifrolumab in reducing disease activity as measured by the BILAG-Based Composite Lupus Assessment (BICLA) scale. In TULIP-1, 457 eligible patients were randomised (1:2:2) and received a fixed-dose intravenous infusion of 150mg anifrolumab, 300mg anifrolumab or placebo every four weeks, 1-methyl-4-{[({[({[({[(1-methyl-1H-pyrrol-2-yl)carbonyl]amino}-1-methyl-1H-pyrrol-2-yl)carbonyl]amino}-1H-pyrrol-2-yl)carbonyl]amino}-1H-pyrrol-2-yl)carbonyl]amino}-1H-pyrrole-2-carboxylic acid suppliers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. 1-[(5-bromo-2-thienyl)methyl]-3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one sodium salt vendor & factory.
